Background. We evaluated the patterns of care and clinical outcomes of metastatic breast cancer patients treated with first-line trastuzumab-based therapy after previous (neo)adjuvant trastuzumab. Materials and Methods. A total of 416 consecutive, HER2-positive metastatic breast cancer patients who had received first-line trastuzumab-based...
-
2015 (v1)PublicationUploaded on: April 14, 2023
-
2017 (v1)Publication
This was a multicenter retrospective cohort study comparing the patterns of care and clinical outcomes of 416 HER2-positive metastatic breast cancer patients with de novo or recurrent disease undergoing first-line trastuzumab-based therapy. Patients with de novo disease showed significantly better survival outcomes than those with recurrent...
Uploaded on: March 27, 2023 -
2020 (v1)Publication
No description
Uploaded on: April 14, 2023